Plasma Resilience: Europe's Lifeline
Human plasma, a protein-rich liquid making up 55% of our blood, is crucial for developing therapies for various conditions, including rare inherited disorders and immunodeficiencies.
Despite its importance, Europe's plasma supply chain is vulnerable, relying on human donations to produce life-saving therapies.
- Over 12 million people in Europe donate plasma annually.
- Donations are governed by EU Member States' safety standards and international standards like the International Quality Plasma Program (IQPP).
- The Plasma Protein Therapeutics Association (PPTA) oversees the process.
However, Europe still imports nearly 40% of its plasma from the United States, highlighting the need to strengthen its plasma supply chain.
Therapies made from plasma exist only thanks to the generosity of real people.
A strong and resilient plasma supply chain is essential for Europe's healthcare system.
Author's summary: Europe relies heavily on human plasma donations.